DD145269A5 - Verfahren zur herstellung neuer thiosubstituierter diazacycloalkene - Google Patents

Verfahren zur herstellung neuer thiosubstituierter diazacycloalkene Download PDF

Info

Publication number
DD145269A5
DD145269A5 DD79214862A DD21486279A DD145269A5 DD 145269 A5 DD145269 A5 DD 145269A5 DD 79214862 A DD79214862 A DD 79214862A DD 21486279 A DD21486279 A DD 21486279A DD 145269 A5 DD145269 A5 DD 145269A5
Authority
DD
German Democratic Republic
Prior art keywords
salt
compound
formula
optionally
items
Prior art date
Application number
DD79214862A
Other languages
German (de)
English (en)
Inventor
Pier G Ferrini
Richard Goeschke
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD145269A5 publication Critical patent/DD145269A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Luminescent Compositions (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
DD79214862A 1978-08-10 1979-08-08 Verfahren zur herstellung neuer thiosubstituierter diazacycloalkene DD145269A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH852678 1978-08-10

Publications (1)

Publication Number Publication Date
DD145269A5 true DD145269A5 (de) 1980-12-03

Family

ID=4341567

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79214862A DD145269A5 (de) 1978-08-10 1979-08-08 Verfahren zur herstellung neuer thiosubstituierter diazacycloalkene

Country Status (15)

Country Link
US (1) US4308277A (xx)
EP (1) EP0008073A1 (xx)
JP (1) JPS5547660A (xx)
AU (1) AU4973979A (xx)
CA (1) CA1130288A (xx)
DD (1) DD145269A5 (xx)
DK (1) DK333279A (xx)
ES (1) ES483247A1 (xx)
FI (1) FI792449A (xx)
GR (1) GR72493B (xx)
IL (1) IL58007A0 (xx)
NO (1) NO792597L (xx)
PL (2) PL224554A1 (xx)
PT (1) PT70046A (xx)
ZA (1) ZA794156B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1302A (en) * 1978-04-11 1985-12-06 Ciba Geigy Ag Mercapto-imidazole derivatives,their preparation,their pharmaceutical compositions and applications
DE3337181A1 (de) * 1983-10-13 1985-04-25 Hoechst Ag, 6230 Frankfurt Neue 4-substituierte-(delta) 2-imidazolinyl-thioether und verfahren zu ihrer herstellung
DE3337180A1 (de) * 1983-10-13 1985-04-25 Hoechst Ag, 6230 Frankfurt Neue 5-substituierte -(delta)2-imidazolinyl-thioether und verfahren zu iherer herstellung
US4686231A (en) * 1985-12-12 1987-08-11 Smithkline Beckman Corporation Inhibition of 5-lipoxygenase products
US4780470A (en) * 1986-08-19 1988-10-25 Smithkline Beckman Corporation Inhibition of interleukin-1 by monocytes and/or macrophages
GB0324498D0 (en) * 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2981739A (en) * 1958-01-27 1961-04-25 Diamond Alkali Co Certain alpha-haloaldehyde addition products of ethylenethioureas and process
SE428686B (sv) * 1975-08-11 1983-07-18 Du Pont Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler
US4190666A (en) * 1975-08-11 1980-02-26 E. I. Du Pont De Nemours And Company Anti-inflammatory 4,5-diarly-2-(substituted-thio)imidazoles and their corresponding sulfoxides and sulfones
ZA78768B (en) * 1977-02-09 1979-01-31 Du Pont Anti-inflammatory imidazoles and their corresponding sulfoxides and sulfones
US4182769A (en) * 1977-02-09 1980-01-08 E. I. Du Pont De Nemours And Company Anti-inflammatory 1-substituted-4,5-diaryl-2-(substituted-thio) imidazoles and their corresponding sulfoxides and sulfones

Also Published As

Publication number Publication date
JPS5547660A (en) 1980-04-04
PT70046A (en) 1979-09-01
ES483247A1 (es) 1980-04-16
NO792597L (no) 1980-02-12
EP0008073A1 (de) 1980-02-20
GR72493B (xx) 1983-11-15
AU4973979A (en) 1980-02-14
IL58007A0 (en) 1979-12-30
ZA794156B (en) 1980-08-27
CA1130288A (en) 1982-08-24
DK333279A (da) 1980-02-11
PL224554A1 (xx) 1982-02-01
US4308277A (en) 1981-12-29
PL217683A1 (xx) 1980-11-03
FI792449A (fi) 1980-02-11

Similar Documents

Publication Publication Date Title
DE2923815C2 (xx)
EP0068261B1 (de) N-Oxacyclyl-Alkylpiperidin-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Präparate und deren Verwendung
EP0041215B1 (de) Imidazoazolalkensäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE3141198A1 (de) 4,5-polymethylen-4-isothiazolin-3-one, verfahren zu deren herstellung und ihre verwendung als bakterizide und fungizide mittel
EP0004648B1 (de) Neue Mercaptoimidazolderivate, Verfahren zu deren Herstellung, Mercaptoimidazolderivate zur Behandlung entzündlicher Erkrankungen und diese enthaltende pharmazeutische Präparate
CH646426A5 (en) Process for the preparation of hydantoin derivatives
EP0163260B1 (de) Neue substituierte Pyrrolidinone, Verfahren zu ihrer Herstellung und Arzneimittel
DD202292A5 (de) Verfahren zur herstellung von neuen n-oxiden von n-oxacyclyl-alkyl-piperidyl-diazaverbindungen
DD145269A5 (de) Verfahren zur herstellung neuer thiosubstituierter diazacycloalkene
DE3103372A1 (de) Neue indanyl-derivate, ihre herstellung und verwendung
EP0298921B1 (de) 1,2-Benzisoxazole und 1,2-Benzisothiazole
DE2534962C3 (de) cis-3,4-Ureylenthiophan-l,l-dioxid und Verfahren zu seiner Herstellung
DE2366237C2 (de) 4-[2-(2-Methoxynicotinamido)äthyl]-1-piperidinsulfonamid
EP0124630B1 (de) Pyrimidin-Thioalkylpyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindung enthaltende Arzneimittel
DD201788A5 (de) Verfahren zur herstellung neuer diaryl-imidazol-verbindungen
EP0008367A1 (de) N-Arylsulfonylpyrrole, ihre Herstellung und diese enthaltende therapeutische Mittel
EP0088323B1 (de) Imidazothiadiazolalkencarbonsäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE2054142A1 (de) Pyridinsulfonsauren
DE3715763A1 (de) Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel
DE2217329A1 (de) Benzofuranderivate
AT374198B (de) Verfahren zur herstellung neuer 2-substituierter mercaptoimidazolderivate, ihrer n-oxyde und ihrer salze
DE2752020A1 (de) Neue 2-sulfonyl (bzw. -sulfinyl)-2'- aminoacetophenone und verfahren zu ihrer herstellung
DD234005A5 (de) Verfahren zur herstellung neuer 1,2,4-triazacycloalkadienderivate
DE2341229A1 (de) Piperidin-derivate und verfahren zu ihrer herstellung
DE2901476C3 (de) N-(Tetrazol-5-yl)-prostaglandin-carboxamide